News
Article
Author(s):
This review of the latest dermatologic studies includes insights into psoriatic lesions and PsA, adipose mesenchymal stem cell-derived exosomes versus platelet-rich plasma, and more.
A study investigated the timing of psoriatic arthritis (PsA) onset relative to psoriasis diagnosis, challenging the common belief that skin lesions precede joint symptoms. Using a single-center retrospective chart review of electronic health records from a large tertiary care center, the study evaluated patients diagnosed with arthritis prior to psoriasis, atopic dermatitis, or rosacea between January 1 and December 31, 2023. The results showed that 14.3% of psoriasis patients had a preceding arthritis diagnosis, compared to 6.8% of rosacea patients and 2.4% of eczema patients, with a statistically significant difference.1
A study compared adipose mesenchymal stem cell-derived exosomes and platelet-rich plasma (PRP) for treating photoaged facial skin. In a split-face, investigator-blinded trial, participants received radiofrequency microneedling with PRP on 1 side and exosomes on the other. Results showed comparable improvements in wrinkles, pigmentation, redness, texture, and overall skin appearance, with histology confirming increased collagen and glycosaminoglycans.2
A study evaluated the accuracy of 3D total body photography (TBP) for assessing mycosis fungoides compared to in-person evaluations, addressing a gap in teledermatology data for this condition. Thirteen patients with mycosis fungoides were assessed using the modified Severity Weighted Assessment Tool both in-person and via 3D TBP images reviewed eight weeks later. Results showed moderate to good agreement between in-person and virtual assessments (ICC = 0.71–0.80), with strong test–retest reliability (ICC = 0.79). While 3D TBP missed areas like the scalp and soles, the study concluded it offers a reliable alternative to in-person assessment and supports its potential use in remote mycosis fungoides management.3
A global survey studied laboratory testing practices for alopecia areata among 214 hair experts across 14 countries to assess variation in clinical approach and alignment with guidelines. Findings showed wide variability: most experts ordered thyroid function (73.4%) and complete blood count (65.9%), while fewer tested for mimics (24.3%) or nutritional factors (39.7%). Testing increased when initiating Janus kinase inhibitor therapy, including lipid profiles, hepatitis panels, and tuberculosis screening. The study concluded that real-world practices vary significantly.4
A study evaluated the effects of a supplement containing an herbal mixture (Venerinase), B-vitamins, zinc, and magnesium on preventing photoaging. Forty participants were randomized to receive either the supplement or a placebo, with assessments at baseline, 2 months, and 4 months. Results showed a significant reduction in the Griffith scale score (from 4.5 to 3.76), indicating improved photoaging. VISIA 2D images revealed a decrease in red areas and a borderline reduction in wrinkles. OCT analysis showed a borderline decrease in collagen density.5
References
What new studies have you been involved with or authored? Share with us by emailing DTEditor@mmhgroup.com for an opportunity to be featured.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.